Mark Lin, APRN

Mark Lin practices at Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami.

Mark Lin's NPI, 1821762600, was assigned on August 4, 2021. Mark Lin holds Florida license APRN10115591.

Mark Lin's primary practice is Sylvester Comprehensive Cancer Center, at 1475 Nw 12th Ave, Miami, FL 33136.

Mark Lin's primary practice is Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami. The medical group on file is University of Miami Health System. Dmand AI also links Mark Lin to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Mark Lin practices, 2 sites in all. Vendor and product names are available with a free account.

Family is Mark Lin's primary specialty in the NPI Registry, under taxonomy code 363LF0000X. Mark Lin is licensed in Florida.

CMS counts 62 Medicare patients who saw Mark Lin in 2024. The largest group is 75 to 84, with 29 patients. 75% of them have high cholesterol, and 73% have high blood pressure. 18% are also on Medicaid. Their average risk score is 1.80, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Mark Lin's median patient age at 66, with 81% women.

In 2024, Mark Lin wrote 67 Medicare Part D claims for 43 patients. 96% of them were for generic drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Mark Lin for performance year 2024, reported as part of a group. Mark Lin accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Mark Lin as offering telehealth.

CMS Open Payments shows 3 general payments to Mark Lin from 3 drug and device companies in 2025. Food and beverage make up the largest share, 100% of the total. TerSera Therapeutics LLC paid the most, $25.